Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Organize a follow-up meeting focused on diagnostics for children in Q1 2018
Co-Chairs of the AIDS Free Working Group of the Start Free, Stay Free, AIDS Free framework
Sub-Actions & Milestones
Organize a High-Level Dialogue on Diagnostics in 2018, with preparatory meetings and consultations with manufacturers and other stakeholders to address the bottlenecks that limit access to EID products and programs; and to scale up strategies that can help quickly identify children and link them to treatment services.
WHO, EGPAF and partners
Dicastery of Integral Human Development, WHO, EGPAF, PEPFAR, UNAIDS, and in collaboration with Caritas Internationalis and WCC-EAA
PEPFAR organized a technical consultation on 9 February to link OVC and paediatric implementing partners to share best practices, particularly around finding well children, as well as evaluating and prioritizing strategies for identifying CLHIV outside of traditional, facility-based settings.
PEPFAR hosted a consultation on diagnostic products on the occasion of the 2018 BMGF Drug Development Partner CMC Forum on 29 March, 2018 in New York City.
On 19/20 April 2018, WHO convened the AIDS Medicines and Diagnostics Service (AMDS), a network of technical partners providing support and guidance to countries in procurement and supply management of HIV commodities.
On 21 – 27 July 2018, WCC-EAA and CHAN organised a follow-up case finding meeting at AIDS 2018, Amsterdam, IAC 2018.
Pre-AIDS 2018 joint meeting with manufacturers, partners, and countries. Hosted by WHO, EGPAF and AIDS Free Partners.
Rome 4: High Level Dialogue Vatican 6-7 December 2018
Milestone completed. See technical consultation recommendations in document section.
Preparation for consultation and planning for preparatory meetings with manufacturers and on case finding.
WHO, EGPAF and partners
WHO, EGPAF, PEPFAR and WCC-EAA have begun discussions on more additional meetings on pediatric diagnostics in Q1 and Q2 of 2018; and about a high-level dialogue on diagnostics in december 2018.
Diagnostics concept paper prepared. To be discussed amongst AIDS Free partners.
On February 9, 2018, PEPFAR convened over fifty technical experts in Washington, D.C. to address challenges in pediatric HIV case finding, and specifically identification of pre-adolescent children with HIV before they present to facilities with illness. Specifically, the meeting focused on finding younger asymptomatic children living with HIV (<10-12 years old) outside the usual facility-based testing (PITC) and routine PMTCT programs with special interest in using OVC, faith-based, school, and other community platforms. This remains a significant issue for all implementing partners. By the end of the meeting the group developed recommendations for: Effective strategies that can be widely adopted, perhaps with adaptation to context; Strategies that show promise in pilot or small-scale, which should be further evaluated and/or scaled up; and Creative, novel ideas that can be piloted and tested. George Siberry led and moderated the discussion. Ambassador Birx provided opening remarks. Others in attendance were representatives from CMMB, Elizabeth Glaser Pediatric AIDS Foundation, ELMA, FHI360, ICAP, Jhpiego, John Snow, Inc., Mothers2Mothers, Management Sciences for Health, Save the Children, UNICEF, University Research Co., LLC (URC) & Center for Human Services (CHS), ViiV Positive Action, WCC-EAA, World Education Inc., World Health Organziation, and World Vision International.
On March 29, 2018, PEPFAR convened diagnostics companies, donors, and select implementing partners for a one-day Consultation meeting in New York City on shared issues related to pediatric treatment such as strategies to improve access to HIV (and TB) diagnostics for infants and children in lower middle income countries (LMICs). This meeting served as a follow-on meeting to the November 2017 High-Level Dialogue on Scaling-Up Early Diagnosis and Treatment of Children and Adolescents. Ambassador Birx provided opening remarks and participated in side meeting discussions with key attendees. The meeting was attended by individuals from Abbott/Alere, Becton Dickinson, CDC – International Laboratory Branch, Cepheid, Clinton Health Access Initiative, DRW, EGPAF, ELMA, Hologic, Holy See, Orasure, Roche, Columbia University, UNAIDS, UNICEF, UNITAID, WCC-EAA, World Health Organization, and the U.S. Food and Drug Administration. The meeting ended up with concrete action items for diagnostic manufacturers to address to ensure cost efficient and uninterrupted diagnosis services for Children and Adolescents.
WHO, EGPAF, PEPFAR and WCC-EAA have begun discussions on more additional meetings on pediatric diagnostics in Q1 and Q2 of 2018.